Tci Wealth Advisors, Inc. Mirati Therapeutics, Inc. Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	BUY	$41.27 - $98.62 $1,031 - $2,465	25 New	25 $1,000
Q1 2022 Apr 29, 2022	SELL	$75.82 - $150.97 $75 - $150	-1 Closed	0 $0
Q4 2021 Jan 24, 2022	BUY	$132.01 - $190.29 $132 - $190	1 New	1 $0
Q2 2021 Aug 02, 2021	SELL	$144.0 - $179.73 $6,480 - $8,087	-45 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$158.92 - $221.61 $7,151 - $9,972	45 New	45 $8,000

3.57M

36.6K

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.